FOXO1 and hepatocellular carcinoma: Recently, Wilson K.C. Leung and colleagues found Wnt/β-Catenin can activate miR-183/96/182 to inhibit FOXO1 to promote the invasion and metastasis of HCC [25], this suggesting FOXO1 inhibits HCC invasion and metastasis.